---
title: "12 Health Care Stocks Moving In Thursday's Intraday Session"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/295130179.md"
description: "On Thursday, several healthcare stocks experienced significant intraday volatility. Gainers included Creative Medical Tech (up 107.8%), Ensysce Biosciences (up 47.81%), and Iovance Biotherapeutics (up 37.44%). Conversely, major losers featured BioVie (down 51.0%), BillionToOne (down 38.39%), and Biote (down 30.09%). Many of these price movements coincided with the release of Q2 or Q3 earnings reports."
datetime: "2026-08-06T17:06:06.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/295130179.md)
  - [en](https://longbridge.com/en/news/295130179.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/295130179.md)
---

# 12 Health Care Stocks Moving In Thursday's Intraday Session

### Gainers

-   **Creative Medical Tech** (NASDAQ:CELZ) stock increased by 107.8% to $1.39 during Thursday's regular session. The company's market cap stands at $4.3 million.
-   **Ensysce Biosciences** (NASDAQ:ENSC) stock rose 47.81% to $0.54. The company's market cap stands at $5.5 million.
-   **Iovance Biotherapeutics** (NASDAQ:IOVA) shares moved upwards by 37.44% to $5.96. The market value of their outstanding shares is at $1.9 billion. The company's, Q2 earnings came out today.
-   **Myomo** (AMEX:MYO) stock increased by 32.07% to $1.4. The company's market cap stands at $40.9 million. As per the news, the Q2 earnings report came out yesterday.
-   **Insmed** (NASDAQ:INSM) shares increased by 32.05% to $130.76. The company's market cap stands at $21.4 billion. As per the press release, Q2 earnings came out today.
-   **Sight Sciences** (NASDAQ:SGHT) stock moved upwards by 27.74% to $7.09. The company's market cap stands at $301.9 million. As per the press release, Q2 earnings came out yesterday.

### Losers

-   **BioVie** (NASDAQ:BIVI) stock decreased by 51.0% to $1.0 during Thursday's regular session. The company's market cap stands at $15.3 million.
-   **BillionToOne** (NASDAQ:BLLN) shares decreased by 38.39% to $92.4. The market value of their outstanding shares is at $6.8 billion. As per the news, the Q3 earnings report came out yesterday.
-   **Biote** (NASDAQ:BTMD) stock fell 30.09% to $1.58. The market value of their outstanding shares is at $68.5 million. As per the press release, Q2 earnings came out yesterday.
-   **Emergent BioSolutions** (NYSE:EBS) shares declined by 29.78% to $5.29. The company's market cap stands at $390.5 million. As per the news, the Q2 earnings report came out yesterday.
-   **Akebia Therapeutics** (NASDAQ:AKBA) stock declined by 28.69% to $0.92. The company's market cap stands at $346.0 million. The company's, Q2 earnings came out yesterday.
-   **Context Therapeutics** (NASDAQ:CNTX) shares declined by 25.47% to $0.52. The market value of their outstanding shares is at $63.6 million. The company's, Q2 earnings came out yesterday. **See Also:** www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

### Related Stocks

- [BLLN.US](https://longbridge.com/en/quote/BLLN.US.md)
- [CELZ.US](https://longbridge.com/en/quote/CELZ.US.md)
- [BIVI.US](https://longbridge.com/en/quote/BIVI.US.md)
- [BTMD.US](https://longbridge.com/en/quote/BTMD.US.md)
- [IOVA.US](https://longbridge.com/en/quote/IOVA.US.md)
- [ENSC.US](https://longbridge.com/en/quote/ENSC.US.md)
- [MYO.US](https://longbridge.com/en/quote/MYO.US.md)
- [INSM.US](https://longbridge.com/en/quote/INSM.US.md)
- [SGHT.US](https://longbridge.com/en/quote/SGHT.US.md)
- [EBS.US](https://longbridge.com/en/quote/EBS.US.md)
- [AKBA.US](https://longbridge.com/en/quote/AKBA.US.md)
- [CNTX.US](https://longbridge.com/en/quote/CNTX.US.md)
- [ENSCW.US](https://longbridge.com/en/quote/ENSCW.US.md)
- [BIVIW.US](https://longbridge.com/en/quote/BIVIW.US.md)

## Related News & Research

- [Ensysce Biosciences posts investor presentation spotlighting trypsin-controlled opioid platforms, pain pipeline](https://longbridge.com/en/news/295107304.md)
- [BioVie says Phase 2 SUNRISE-PD trial shows bezisterim improves motor and non-motor symptoms in early Parkinson’s disease](https://longbridge.com/en/news/295101020.md)
- [Renaissance Technologies LLC Takes $4.05 Million Position in Billiontoone, Inc. $BLLN](https://longbridge.com/en/news/295296145.md)
- [BillionToOne CEO Oguzhan Atay disposes of 15,539 common shares worth $2.33 million](https://longbridge.com/en/news/295272609.md)
- [BioVie posts corporate presentation outlining bezisterim, BIV201 clinical programs in neurodegeneration, Long COVID, liver disease](https://longbridge.com/en/news/295220567.md)